FindTrial
Sign In

Efficacy of Low-Dose Etoposide Combined with PEG-G-CSF for Peripheral Blood Stem Cell Mobilization in Multiple Myeloma

Efficacy of Low-Dose Etoposide Combined with PEG-G-CSF for Peripheral Blood Stem Cell Mobilization in Multiple Myeloma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600115897
Enrollment
Unknown
Registered
2026-01-04
Start date
2026-01-15
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Myeloma

Interventions

Etoposide+PEG G-CSF:None

Sponsors

The Second Affiliated Hospital of Hainan Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with multiple myeloma in the Department of Hematology of the Second Affiliated Hospital of Hainan Medical University from January 2022 to January 2025, meeting the IMWG diagnostic criteria; 2. Age over 18 years old; 3. Multiple myeloma patients who received peripheral blood stem cell mobilization with etoposide combined with PEG-rhG-CSF; 4. Patients gave informed consent.

Exclusion criteria

Exclusion criteria: Multiple myeloma patients undergoing peripheral blood stem cell mobilization without etoposide combined with PEG G-CSF

Design outcomes

Primary

MeasureTime frame
post-mobilization peripheral blood collection stem cell count;post-mobilization peripheral blood CD34/nucleated cell ratio;—

Secondary

MeasureTime frame
Post-mobilization peripheral blood white blood cell count;post-mobilization peripheral blood collection CD34/nucleated cell ratio;post-mobilization peripheral blood absolute CD34 count; post-transplantation neutrophil engraftment time;—

Countries

China

Contacts

Public ContactMin Dong

The Second Affiliated Hospital of Hainan Medical University

dm1175@sina.com+86 133 7731 1789

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026